Cargando…
Efficacy of Anti-TNF Therapy for the Treatment of Patients with Moderate-to-Severe Inflammatory Bowel Disease; a First Iranian Report
BACKGROUND The anti-TNF drugs are shown to be highly effective in treatment of patients with moderate-tosevere inflammatory bowel disease (IBD). Here, we aimed to assess the efficacy and safety of antiTNF therapy at the national level. METHODS IBD patients aged 15 > years who received Infliximab...
Autores principales: | Mohagheghi Darehranj, Samaneh, Alatab, Sudabeh, Vahedi, Homayoon, Sadeghi, Anahita, Sima, Alireza, Malekzadeh, Masoud, Anoshiravani, Amir, Fakheri, Hafez, Ebrahimi Daryani, Nasser, Mousavi, Abdolhamid, Mansour-Ghanaei, Fariborz, Zahedi, Mohammad Javad, Malekzadeh, Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iranian Association of Gastroerterology and Hepatology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023648/ https://www.ncbi.nlm.nih.gov/pubmed/32082516 http://dx.doi.org/10.15171/mejdd.2020.158 |
Ejemplares similares
-
Iranian Registry of Crohn’s and Colitis: study profile of first nation-wide inflammatory bowel disease registry in Middle East
por: Malekzadeh, Masoud M, et al.
Publicado: (2019) -
A Supporting System for Management of Patients with Inflammatory Bowel Disease during COVID-19 Outbreak: Iranian Experience-Study Protocol
por: Anushiravani, Amir, et al.
Publicado: (2020) -
Susceptibility of Patients with Inflammatory Bowel Disease to COVID-19 Compared with Their Households
por: Anushiravani, Amir, et al.
Publicado: (2022) -
Iranian Consensus Guideline for Pharmacotherapy with Biologics and Small Molecules Drugs in Adults with Inflammatory Bowel Diseases
por: Khoshnam-Rad, Niloofar, et al.
Publicado: (2023) -
Nonadherence to Medication in Inflammatory Bowel Disease: Rate and Reasons
por: Ghadir, Mohammad Reza, et al.
Publicado: (2016)